The news also points out that Sanger sequencing continues to play an important role in the DNA sequencing ecosystem. No other sequencing technology is suitable for doing a large number of small things. Thus, researchers access to Sanger systems will continue to play an important role in confirming clones, sequencing individual PCR products, and validating the results of NGS experiments. As many labs sunset their Sanger equipment in favor of NGS equipment, services such as those provided by Eurofins MWG Operon will continue to grow in importance, and we are thrilled to help.
Of course, the GeneSifter LIMS (GSLE) does much more than Sanger sequencing. Our NGS support is highly regarded, along with our microarray support as discussed in recent blogs announcing the current GSLE release and our recent news about PacBio.
Other product strengths include GSLE's configurability and application programming interfaces (APIs). Supporting worldwide deployment means non-english speakers within labs need to be able to communicate and use their words in forms and instructions. Using GSLE's standard web interfaces groups can internationalize parts of the system with their own language terms and comments to help their work. Finally, using GSLE's APIs Eurofins MWG Operon has easily incorporated the system into their web site to provide their customers with a smooth experience.